B. Metzler seel. Sohn & Co’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
VCM
VPM
B. Metzler seel. Sohn & Co's DXCM Position: Q1 2026 in Review
B. Metzler seel. Sohn & Co increased its DexCom (DXCM) stake by 54% in Q1 2026, buying an estimated $1.13M and bringing the position to 46,347 shares worth $2.91M. The position accounts for 0.03% of the portfolio, ranked #302.
B. Metzler seel. Sohn & Co first reported a position in DXCM in Q4 2020 and has held it in 22 quarters since. The position peaked at $20.2M in Q4 2021. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- B. Metzler seel. Sohn & Co held 46,347 shares of DexCom worth $2.91M as of Q1 2026.
- B. Metzler seel. Sohn & Co bought 16,293 DexCom shares in Q1 2026, an estimated $1.13M.
- DexCom made up 0.03% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #302 holding.
- B. Metzler seel. Sohn & Co first reported a position in DexCom in Q4 2020 and has held it in 22 quarters since.
- B. Metzler seel. Sohn & Co's DexCom position peaked at $20.2M in Q4 2021.
- 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.